UBS Opportunistic Equity Income (S:0P0001JFEZ)
17.62
+0.62
(+3.65%)
USD |
Sep 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of January 13, 2026.
*Indicates data for the year is incomplete.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| JPMorgan Chase & Co. | 6.28% | 324.49 | -1.43% |
| Alphabet, Inc. | 4.82% | 331.86 | 1.00% |
| Walmart, Inc. | 4.64% | 117.97 | 3.00% |
| Johnson & Johnson | 4.50% | 209.72 | 2.61% |
| RTX Corp. | 4.33% | 193.85 | 2.84% |
| Johnson Controls International Plc | 3.64% | 111.39 | 0.49% |
| The Goldman Sachs Group, Inc. | 3.46% | 949.55 | 1.13% |
| AstraZeneca PLC | 3.44% | 93.63 | -1.08% |
| Wells Fargo & Co. | 3.43% | 94.96 | -1.03% |
| AbbVie, Inc. | 3.39% | 220.04 | -0.02% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |